Vanguard Personalized Indexing Management, LLC
Position in QNCX — Quince Therapeutics, Inc.
CIK 1767306
OAKLAND, CA
Position in QNCX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$13,398
New position
Shares Held
663
first reported quarter
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 84%
Shared 0%
None 16%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vanguard Personalized Indexing Management, LLC holds $97,369,187 across 138 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,151 | $21,434,396 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,712 | $7,302,900 | |
| 3 | INCY |
Incyte Corp
|
34,556 | $3,917,268 | |
| 4 | ARGX |
Argenx SE
|
4,103 | $3,806,640 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,436 | $3,442,579 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
17,697 | $3,314,294 | |
| 7 | MRNA |
Moderna, Inc.
|
43,679 | $3,058,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
30,414 | $2,380,503 |
All Filings in QNCX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,398 | 132,661 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||